Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.

New research suggests a blood test may identify Alzheimer’s years before it is detectable on scans. Image credit: Sean Locke/Stocksy At present, diagnosis typically involves a combination of medical ...

A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...

A new study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid ...

A new study has found that soft 3D-printed brain sensors can follow individual brain folds more closely than standard rigid ...

It's widely recognized that psychiatric conditions like depression and anxiety disorders are based in the brain. Scientists have even started to discover which brain areas are involved in different ...

Individuals with high levels of psychopathy tend to struggle with feeling concern for others, and new research links these ...